Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Biologic Therapy in Stages III/IV Head and Neck Squamous Cell Carcinoma
NCT00054561Phase 3Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Nov 2003
- Primary completion
- Dec 2004
- Modality
- Cytokines & Interferons, Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of isotretinoin, interferon alfa in head and neck squamous cell carcinoma (HNSCC), sponsored by Eastern Cooperative Oncology Group. Started Nov 2003; status: completed.
02
Drugs
isotretinoininterferon alfa
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00054561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00054561.